Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Pastrami on Rye -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (53)	5/9/2007 3:24:01 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 379

I see three Curis boards to choose from, none are active. siliconinvestor.com Oh well. Anyway, from the quarterly report... As of March 31, 2007, cash, cash equivalents, marketable securities and investments were $32,740,000 and there were 49,373,967 shares of common stock outstanding. "We experienced two key accomplishments during the first quarter of 2007 - the initiation of a Phase I clinical trial of a systemically administered Hedgehog antagonist for the treatment of cancer and the advancement of CUDC-101, a proprietary and wholly-Curis owned cancer drug candidate, to development candidate status," said Daniel Passeri, Curis' President and Chief Executive Officer. "We have been actively working toward our goal of filing an IND for CUDC-101 by early 2008, while at the same time engaging in potential collaboration discussions for this class of molecules. We remain hopeful that we may be in a position to consummate a collaboration during the second half of 2007. While we advance CUDC-101 toward clinical testing, we are also seeking to continue to advance other drug candidates in our Targeted Cancer Drug Development Platform, including a multi-target inhibitor that is designed to inhibit HSP90 and the same non-kinase target in CUDC-101. We are hopeful that we can advance at least one additional compound into development candidate status in late 2007 or early 2008." phx.corporate-ir.net